Author

Bing Liu

Second Military Medical UniversityORCID 0000-0003-4413-4492Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bing Liu3 papers · First Affiliated Hospital of Xi'an Jiaotong University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aimin JiangiD· 1 shared Anbang WangiD· 1 shared Jie WangiD· 1 shared Juan LüiD· 1 shared Linhui WangiD· 1 shared Wenliang Gong· 1 shared Xinxin GaniD· 1 shared Yewei BaoiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aimin JiangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsOxidative Medicine and Cellular LongevityPeer-reviewedJan 1, 2022

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multi-Omics Data Analysis

Aimin Jiang, Yewei Bao, Anbang Wang…·Linhui Wang

The paper develops a prognostic model and drug selection framework for clear cell renal cell carcinoma using multi-omics data from TCGA, identifying high- and low-risk patient subtypes with significant survival differences.

19 citations

humanbulk RNA-seq

𝕏 PostBluesky